Chinese Firm Sinopharm Reports Promising Results for COVID-19 Vaccine Trials
The anti-Covid vaccine from the Chinese pharmaceutical group Sinopharm, chosen by Morocco, is about to be completed thanks to the results of clinical trials.
In a press release, the pharmaceutical group indicated on Wednesday, November 11 that the data obtained from the large-scale clinical trials were "better than expected".
According to Reuters, the 3rd phase of clinical trials has been launched for the two vaccine candidates by China National Biotec Group (CNBG), which is a Sinopharm unit. These trials have been conducted in the United Arab Emirates, Bahrain and Egypt on more than 50,000 volunteers from these countries.
Pending the completion of the trials, the group should provide more details on the data from the trials of one of the two group’s vaccines.
Related Articles
-
Morocco Blocks Extradition of Crypto Kidnapping Suspect to France
7 June 2025
-
Casablanca’s $7 Million Coastal Promenade Project Rejected Amid Quality Concerns
6 June 2025
-
New Moroccan Dinosaur Discovery Challenges Ancient Continental Isolation Theory
6 June 2025
-
Survey: 90% of Moroccans Face Daily Incivility, Lack of Civic Behavior
6 June 2025
-
Moroccan Activist Sentenced to Two Years for Anti-Israel Facebook Posts
6 June 2025